TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403,309 | -20.0% | 10,695 | -19.6% | 0.07% | -26.8% |
| Q2 2023 | $504,390 | +99.8% | 13,298 | +28.1% | 0.10% | +67.2% |
| Q1 2023 | $252,409 | +11.2% | 10,379 | +32.8% | 0.06% | +1.8% |
| Q4 2022 | $226,936 | +9.6% | 7,815 | +13.2% | 0.06% | 0.0% |
| Q3 2022 | $207,000 | +155.6% | 6,902 | +522.9% | 0.06% | +90.0% |
| Q4 2020 | $81,000 | – | 1,108 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
| ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
| Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
| Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
| Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
| BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
| FORT, L.P. | 9,672 | $730,000 | 0.14% |
| CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
| ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |